The Effects of Covid-19 Vaccination on Menstruation: Are women with underlying reproductive health conditions, particularly black women at a higher risk for vaccine-related menstruation complications?

OA: closed
📄 Open PDF View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-08-04

This study surveyed women about COVID-19 vaccination's menstrual effects, finding Pfizer's vaccine most linked to changes, particularly in women of color with reproductive health conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The study investigates the potential impact of COVID-19 vaccines on menstrual cycles, with a particular focus on Black women and those with underlying reproductive health conditions. Despite numerous reports of menstrual irregularities post-vaccination, research on this subject remains limited. The study aims to explore whether these irregular cycles could indicate broader reproductive health concerns, such as reduced ovarian reserve, and whether certain vaccines are more likely to cause these changes. It also examines the concept of «contraceptive masking,» where hormonal contraceptives may mask the true extent of underlying reproductive health issues. A survey was conducted among women of diverse racial and geographical backgrounds to assess changes in menstruation following COVID-19 vaccination. The findings revealed that Pfizer's vaccine was most associated with menstrual changes, including heavier and longer periods, particularly after the second dose. In some cases, women who rarely menstruated before vaccination began to experience cycles post-vaccination. The study also suggests that vaccination timing relative to the menstrual cycle may influence these changes. Women of color, especially Black women, may be at higher risk for vaccine-related menstrual disturbances due to a higher prevalence of conditions like fibroids. The research emphasizes the need for further studies on the effects of COVID-19 vaccines on menstruation, particularly among women of color and those with reproductive health conditions. It also calls for individualized treatment plans to address these potential side effects and prevent serious conditions, such as premature ovarian failure, from being overlooked.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-08-23T09:30:01.253652+00:00